Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)

Guidance Document - Pharmaceutical Development ICH Topic Q8(R2) This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA. 2023-12-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyguidance documentpharmaceutical developmentICH Topic Q8(R2) Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/quality/pharmaceutical-development-topic.html Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/qualite/developpement-pharmaceutique-theme.html

This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. The ICH Steering Committee has endorsed the final draft and recommended its adoption by the regulatory bodies of the European Union, Japan and USA.

Data and Resources

Similar records